Evidence map›Paper›PMID 19301472›Full record

ArticleHuman gene therapy2009

Prolonged transgene expression with lentiviral vectors in the aqueous humor outflow pathway of nonhuman primates.

Román A Barraza, Carol A Rasmussen, Nils Loewen, J Douglas Cameron, B'Ann T Gabelt, Wu-Lin Teo, Paul L Kaufman, Eric M Poeschla

Open access · greenAbstract read
In one paragraph

Article in Human gene therapy, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 50 citations in OpenAlex.

  1. Evaluation of trabecular meshwork-specific promotersInternational journal of ophthalmology · 2023
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Lentiviral Vector-Mediated Expression of Exoenzyme C3 Transferase Lowers Intraocular Pressure in Monkeys.Molecular therapy : the journal of the American Society of Gene Therapy · 2019
    Article
  10. Review
  11. Article
  12. Gene transfer to the outflow tract.Experimental eye research · 2017
    Review
  13. Article
  14. Review
  15. Exciting directions in glaucoma.Canadian journal of ophthalmology. Journal canadien d'ophtalmologie · 2014
    Review
  16. Review
  17. Article
  18. Article
  19. A Potential Application of Canaloplasty in Glaucoma Gene Therapy.Translational vision science & technology · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Román A BarrazaDepartment of Molecular Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
Carol A Rasmussen
Nils Loewen
J Douglas Cameron
B'Ann T Gabelt
Wu-Lin Teo
Paul L Kaufman
Eric M Poeschla
Mayo Clinic · US

Funding

UW Vision Research Core - Administrative CoreP30EY016665 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI ROBERT W NICKELLS · 2005 to 2026
$12.6M
ANTERIOR OCULAR SEGMENT PHYSIOLOGY AND PHARMACOLOGYR01EY002698 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI KAUFMAN, PAUL L · 1985 to 2009
$4.5M
Lentiviral Transgenesis of the Aqueous Outflow TractR01EY014411 · NEI · MAYO CLINIC ROCHESTER · PI POESCHLA, ERIC M. · 2003 to 2011
$3.4M
NOVEL LENTIVIRAL VECTORS FOR SUSTAINED GENE EXPRESSIONR01AI047536 · NIAID · MAYO CLINIC ROCHESTER · PI POESCHLA, ERIC M. · 1999 to 2008
$1.8M
NEI NIH HHS P30 EY 016665NEI NIH HHS P30 EY016665NEI NIH HHS R01 EY 002698NEI NIH HHS R01 EY002698NEI NIH HHS R01 EY014411NEI NIH HHS R01 EY 14411NIAID NIH HHS R01 AI 47536
6 · The paper itself

Abstract

We injected lentiviral vectors into the eyes of live nonhuman primates to assess potential for glaucoma gene therapy. Anterior chambers of five cynomolgus monkeys were injected with green fluorescent protein (GFP)-encoding feline immunodeficiency viral vectors. The monkeys were monitored for in vivo transgene expression and clinical parameters. Their eyes were harvested 2-15 months postinjection for tissue analyses. All seven eyes injected with 1.0-2.0 x 10(8) transducing units (TU) showed substantial GFP fluorescence in the trabecular meshwork (TM), which was observable even by goniophotographic monitoring for up to 15 months. Only the lowest dose (0.03 x 10(8) TU) failed to result in TM fluorescence detectable in vivo, and five of the eight vector-injected eyes continued to display substantial GFP expression when enucleated eyes were examined at 2, 7, or 15 months postinjection. Some transduced cells were also detected in the iris and ciliary body. Mild, transient postinjection inflammatory responses exceeding that induced by a control saline injection were observed, but vectors did not raise intraocular pressure and were well tolerated. The results demonstrate the first lentiviral vector transduction of the nonhuman primate aqueous humor outflow pathway and support application of the system to human glaucoma gene therapy.

Indexed as

AnimalsAqueous HumorCiliary BodyFemaleGenetic TherapyGenetic VectorsGlaucoma, Open-AngleGreen Fluorescent ProteinsHumansImmunodeficiency Virus, FelineInjectionsIrisMacaca fascicularisMaleRecombinant ProteinsTime FactorsGreen Fluorescent ProteinsRecombinant Proteins

Identifiers

PMID19301472
PMCPMC2855254
OpenAlexW2068418960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.